Brief: Genedx Holdings Corp FY 2025 Revenue Guidance Of $350M To $360M
18/02/2025 11:20
Feb 18 (Reuters) - GeneDx Holdings Corp WGS.O :
* GENEDX HOLDINGS CORP: FY 2025 REVENUE GUIDANCE OF $350M TO
$360M, EXOME/GENOME VOLUME AND REVENUE GROWTH OF AT LEAST 30%
* GENEDX HOLDINGS CORP - FOURTH QUARTER 2024 REVENUES GREW
TO
$95.3 MILLION
Source text: ID:nBwbXVKqqa
Further company coverage: WGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth